Literature DB >> 18779350

Statins alone are ineffective in cerebral malaria but potentiate artesunate.

Anne-Lise Bienvenu, Stéphane Picot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18779350      PMCID： PMC2573154          DOI： 10.1128/AAC.00513-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.

Authors:  Bruno Pradines; Marylin Torrentino-Madamet; Albin Fontaine; Maud Henry; Eric Baret; Joel Mosnier; Sébastien Briolant; Thierry Fusai; Christophe Rogier
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

2.  Statin treatment after onset of sepsis in a murine model improves survival.

Authors:  Marc W Merx; Elisa A Liehn; Jürgen Graf; Annette van de Sandt; Maren Schaltenbrand; Jürgen Schrader; Peter Hanrath; Christian Weber
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

Review 3.  Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.

Authors:  Michael Schachter
Journal:  Fundam Clin Pharmacol       Date:  2005-02       Impact factor: 2.748

4.  HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.

Authors:  Majaz Moonis; Kevin Kane; Ute Schwiderski; Bobby W Sandage; Marc Fisher
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

5.  Recombinant human erythropoietin prevents the death of mice during cerebral malaria.

Authors:  Karine Kaiser; Anthony Texier; Josette Ferrandiz; Alain Buguet; Anne Meiller; Christine Latour; François Peyron; Raymond Cespuglio; Stéphane Picot
Journal:  J Infect Dis       Date:  2006-02-28       Impact factor: 5.226

Review 6.  Statins and sepsis: multiple modifications at multiple levels.

Authors:  Marius Terblanche; Yaniv Almog; Robert S Rosenson; Terry S Smith; Daniel G Hackam
Journal:  Lancet Infect Dis       Date:  2007-05       Impact factor: 25.071

Review 7.  Are pleiotropic effects of statins real?

Authors:  Alberto Corsini; Nicola Ferri; Michele Cortellaro
Journal:  Vasc Health Risk Manag       Date:  2007
  7 in total
  15 in total

1.  Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs.

Authors:  Rina P M Wong; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

2.  Cerebral malaria: a vasculopathy.

Authors:  Mahalia S Desruisseaux; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz; Linnie M Golightly
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

3.  Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin.

Authors:  Hélène Savini; Jean Baptiste Souraud; Sébastien Briolant; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

4.  Antimalarial potential of leaves of Chenopodium ambrosioides L.

Authors:  Dalila Nunes Cysne; Thiare Silva Fortes; Aramys Silva Reis; Bruno de Paulo Ribeiro; Amália Dos Santos Ferreira; Flavia Maria Mendonça do Amaral; Rosane Nassar Meireles Guerra; Claudio Romero Farias Marinho; Roberto Nicolete; Flávia Raquel Fernandes Nascimento
Journal:  Parasitol Res       Date:  2016-08-05       Impact factor: 2.289

5.  Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Authors:  Véronique Parquet; Maud Henry; Nathalie Wurtz; Jerome Dormoi; Sébastien Briolant; Marine Gil; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

6.  Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.

Authors:  Carmen María Martín-Navarro; Jacob Lorenzo-Morales; Rubén P Machin; Atteneri López-Arencibia; José Manuel García-Castellano; Isabel de Fuentes; Brendan Loftus; Sutherland K Maciver; Basilio Valladares; José E Piñero
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

7.  Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.

Authors:  Véronique Parquet; Sébastien Briolant; Marylin Torrentino-Madamet; Maud Henry; Lionel Almeras; Rémy Amalvict; Eric Baret; Thierry Fusaï; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

8.  Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.

Authors:  Jérome Dormoi; Sébastien Briolant; Camille Desgrouas; Bruno Pradines
Journal:  Malar J       Date:  2013-04-15       Impact factor: 2.979

9.  Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.

Authors:  Patricia A Reis; Vanessa Estato; Tathiany I da Silva; Joana C d'Avila; Luciana D Siqueira; Edson F Assis; Patricia T Bozza; Fernando A Bozza; Eduardo V Tibiriça; Guy A Zimmerman; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

10.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.